Mining actinomycetes for novel antibiotics in the omics era: Are we ready to exploit this new paradigm?

Antibiotics

Volumn 7, Issue 4, 2018, Pages

  Genilloud, Olga ^a  

^a Health Sciences Technology Park   (Spain)

Author keywords

Actinomycetes; Antibiotics; Culture based approaches; Omics; Secondary metabolism

Indexed keywords

ALCHIVEMYCIN A; ALCHIVEMYCIN B; ANTHRAMYCIN; ANTIBIOTIC AGENT; ARGOLAPHO A; ARGOLAPHO B; ASENJONAMIDE A; ASENJONAMIDE B; ASENJONAMIDE C; CIROMICIN; DIFLUOSTATIN A; ENTEROCIN; KOCURIN; LASSOMYCIN; MICROMONOHALIMANE A; MICROMONOHALIMANE B; PHOCOENAMICIN B; PHOCOENAMICIN C; SALINAMIDE F; TAROMYCIN A; THIOLACTOMYCIN; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; DRUG STRUCTURE; GENETIC ENGINEERING; GENOMICS; METABOLOMICS; NONHUMAN; OMICS; PROTEOMICS; REVIEW;

EID: 85055342078     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics7040085     Document Type: Review

References (92)

1. Berdy, J.J. Thoughts and facts about antibiotics: Where we are now and where we are heading. J. Antibiot. 2012, 65, 385–395. [CrossRef] [PubMed]
2. Landwehr, W.; Wolf, C.; Wink, J. Actinobacteria and myxobacteria-two of the most important bacterial resources for novel antibiotics. Curr. Top. Microbiol. Immunol. 2016, 398, 273–302. [PubMed]
3. Fischbach, M.A.; Walsh, C.T. Antibiotics for emerging pathogens. Science 2009, 325, 1089–1093. [CrossRef] [PubMed]
4. Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 2011, 24, 71–109. [CrossRef] [PubMed]
5. Walsh, C.T.; Wencewicz, T.A. Prospects for new antibiotics: A molecule-centered perspective. J. Antibiot. 2014, 67, 7–22. [CrossRef] [PubMed]
6. Rex, J.H.; Outterson, K. Antibiotic reimbursement in a sales-delinked model: Context and a benchmark-based global approach. Lancet Infect. Dis. 2016, 16, 500–505. [CrossRef]
7. Editorial. Wanted: A reward for antibiotic development. Nat. Biotechnol. 2018, 36, 555. [CrossRef] [PubMed]
8. Rex, J.H.; Goldberger, M.; Eisenstein, B.; Harney, C. The evolution of the regulatory framework for antibacterial agents. Ann. N. Y. Acad. Sci. 2014, 1323, 11–21. [CrossRef] [PubMed]
9. Simpkin, V.L.; Renwick, M.J.; Kelly, R.; Mossialos, E. Incentivising innovation in antibiotic drug discovery and development: Progress, challenges and next steps. J. Antibiot. 2017, 70, 1087–1096. [CrossRef] [PubMed]
10. Antibiotics Currently in Global Clinical Development. Available online: http://www.pewtrusts.org/-/media/assets/2018/03/antibiotics_clinical_dev_table_february2018.pdf (accessed on 1 February 2018).
11. Brown, E.D.; Wright, G.D. Antibacterial drug discovery in the resistance era. Nature 2016, 529, 336–343. [CrossRef] [PubMed]
12. Payne, D.J.; Gwynn, M.N.; Holmes, D.J.; Pompliano, D.L. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 2007, 6, 29–40. [CrossRef] [PubMed]
13. Silver, L.L. Are natural products still the best source for antibacterial discovery? The bacterial entry factor. Expert Opin. Drug Discov. 2008, 3, 487–500. [CrossRef] [PubMed]
14. Wright, G.D. Something old, something new: Revisiting natural products in antibiotic drug discovery. Can. J. Microbiol. 2014, 60, 147–154. [CrossRef] [PubMed]
15. Lewis, K. New approaches to antimicrobial discovery. Biochem. Pharmacol. 2017, 134, 87–98. [CrossRef] [PubMed]
16. Baltz, R.H. Gifted microbes for genome mining and natural product discovery. J. Ind. Microbiol. Biotechnol. 2017, 44, 573–588. [CrossRef] [PubMed]
17. Nett, M.; Ikeda, H.; Moore, B.S. Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat. Prod. Rep. 2009, 26, 1362–1384. [CrossRef] [PubMed]
18. Rutledge, P.J.; Challis, G.L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 2015, 13, 509–523. [CrossRef] [PubMed]
19. Genilloud, O. Actinomycetes: Still a source of novel antibiotics. Nat. Prod. Rep. 2017, 34, 1203–1232. [CrossRef] [PubMed]
20. Katz, L.; Baltz, R.H. Natural product discovery: Past, present, and future. J. Ind. Microbiol. Biotechnol. 2016, 43, 155–176. [CrossRef] [PubMed]
21. Kealey, C.; Creaven, C.A.; Murphy, C.D.; Brady, C.B. New approaches to antibiotic discovery. Biotechnol. Lett. 2017, 39, 805–817. [CrossRef] [PubMed]
22. Wencewicz, T.A. New antibiotics from nature’s chemical inventory. Bioorg. Med. Chem. 2016, 24, 6227–6252. [CrossRef] [PubMed]
23. Bull, A.T.; Asenjo, J.A.; Goodfellow, M.; Gomez-Silva, B. The atacama desert: Technical resources and the growing importance of novel microbial diversity. Ann. Rev. Microbiol. 2016, 70, 215–234. [CrossRef] [PubMed]
24. Mohammadipanah, F.; Wink, J. Actinobacteria from arid and desert habitats: Diversity and biological activity. Front. Microbiol. 2016, 6, 1541. [CrossRef] [PubMed]
25. Rateb, M.E.; Ebel, R.; Jaspars, M. Natural product diversity of actinobacteria in the atacama desert. Antonie Van Leeuwenhoek 2018, 111, 1467–1477. [CrossRef] [PubMed]
26. Abdelkader, M.S.A.; Philippon, T.; Asenjo, J.A.; Bull, A.T.; Goodfellow, M.; Ebel, R.; Jaspars, M.; Rateb, M.E. Asenjonamides A-C, antibacterial metabolites isolated from Streptomyces asenjonii strain KNN 42.f from an extreme-hyper arid Atacama Desert soil. J. Antibiot. 2018, 71, 425–431. [CrossRef] [PubMed]
27. Ghosh, S.; Kuisiene, N.; Cheeptham, N. The cave microbiome as a source for drug discovery: Reality or pipe dream? Biochem. Pharmacol. 2017, 134, 18–34. [CrossRef] [PubMed]
28. Adam, D.; Maciejewska, M.; Naômé, A.; Martinet, L.; Coppieters, W.; Karim, L.; Baurain, D.; Rigali, S. Isolation, characterization, and antibacterial activity of hard-to-culture actinobacteria from cave moonmilk deposits. Antibiotics 2018, 7, 28–48. [CrossRef] [PubMed]
29. Gavrish, E.; Sit, C.S.; Cao, S.; Kandror, O.; Spoering, A.; Peoples, A.; Ling, L.A.; Hughes, D.; Bissell, A.; Torrey, H.; et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 2014, 21, 509–518. [CrossRef] [PubMed]
30. Jang, K.H.; Nam, S.-J.; Locke, J.B.; Kauffman, C.A.; Beatty, D.S.; Paul, L.A.; Fenical, W. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Chem. Int. Ed. 2013, 52, 7822–7824. [CrossRef] [PubMed]
31. Hassan, H.M.; Degen, D.; Jang, K.H.; Ebright, R.H.; Fenical, W.; Salinamide, F. New depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. J. Antibiot. 2015, 68, 206–209. [CrossRef] [PubMed]
32. Palomo, S.; González, I.; Martín, J.; de la Cruz, M.; Vicente, F.; Reyes, F.; Tormo, J.R.; Anderson, M.; Hill, R.T.O.; Genilloud, O. Sponge-derived Kocuria and Micrococcus spp. as sources of the new thiazolyl peptide antibiotic kocurin. Mar. Drugs 2013, 11, 1071–1086. [CrossRef] [PubMed]
33. Zhang, Y.; Adnani, N.; Braun, D.R.; Ellis, G.A.; Barns, K.J.; Parker-Nance, S.; Guzei, I.A.; Bugni, T.S. Micromonohalimanes A and B: Antibacterial halimane-type diterpenoids from a marine Micromonospora species. J. Nat. Prod. 2016, 79, 2968–2972. [CrossRef] [PubMed]
34. Pérez-Bonilla, M.; Oves-Costales, D.; de la Cruz, M.; Kokkini, M.; Martín, J.; Vicente, F.; Genilloud, O.; Reyes, F. Phocoenamicins B and C, New antibacterial spirotetronates isolated from a marine Micromonospora sp. Mar. Drugs 2018, 16. [CrossRef] [PubMed]
35. Ju, K.-S.; Gao, J.; Doroghazi, J.R.; Wang, K.-K.A.; Thibodeaux, C.J.; Lia, S.; Metzger, E.; Fudala, J.; Su, J.; Zhang, J.K.; et al. Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes. Proc. Natl. Acad. Sci. USA 2015, 112, 12175–12180. [CrossRef] [PubMed]
36. Tang, X.; Li, J.; Millán-Aguiñaga, N.; Zhang, J.J.; O’Neill, E.C.; Ugalde, J.A.; Jensen, P.R.; Mantovani, S.M.; Moore, B.S. Identification of thiotetronic acid antibiotic biosynthetic pathways by target-directed genome mining. ACS Chem. Biol. 2015, 10, 2841–2849. [CrossRef] [PubMed]
37. Yamanaka, K.; Reynolds, K.A.; Kersten, R.D.; Ryan, K.S.; Gonzalez, D.J.; Nizet, V.; Dorrestein, P.C.; Moore, B.S. Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc. Natl. Acad. Sci. USA 2014, 111, 1957–1962. [CrossRef] [PubMed]
38. Bonet, B.; Teufel, R.; Cruüsemann, M.; Ziemert, N.; Moore, B.S. Direct capture and heterologous expression of Salinispora natural product genes for the biosynthesis of enterocin. J. Nat. Prod. 2014, 78, 539–542. [CrossRef] [PubMed]
39. Yang, C.; Huang, C.; Zhang, W.; Zhu, Y.; Zhang, C. Heterologous expression of fluostatin gene cluster leads to a bioactive heterodimer. Org. Lett. 2015, 17, 5324–5327. [CrossRef] [PubMed]
40. Onaka, H. Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes. J. Antibiot. 2017, 70, 865–870. [CrossRef] [PubMed]
41. Derewacz, D.K.; Covington, B.C.; McLean, J.A.; Bachmann, B.O. Mapping microbial response metabolomes for induced natural product discovery. ACS Chem. Biol. 2015, 10, 1998–2006. [CrossRef] [PubMed]
42. Fenical, W.; Jensen, P.R. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2, 666–673. [CrossRef] [PubMed]
43. Bull, A.T.; Stach, J.E.M. Marine actinobacteria: New opportunities for natural product search and discovery. Trends Microbiol. 2007, 15, 491–499. [CrossRef] [PubMed]
44. Choudhary, A.; Naughton, L.M.; Montánchez, I.; Dobson, A.D.W.; Rai, D.K. Current status and future prospects of marine natural products (MNPs) as antimicrobials. Mar. Drugs 2017, 15, 272. [CrossRef] [PubMed]
45. Dhakal, D.; Pokhrel, A.R.; Shrestha, B.; Sohng, J.K. Marine rare actinobacteria: Isolation, characterization, and strategies for harnessing bioactive compounds. Front. Microbiol. 2017, 8, 1106. [CrossRef] [PubMed]
46. Xu, D.; Han, L.; Li, C.; Cao, Q.; Zhu, D.; Barrett, N.H.; Harmody, D.; Chen, J.; Zhu, H.; McCarthy, P.J.; et al. Bioprospecting deep-sea actinobacteria for novel anti-infective natural products. Front. Microbiol. 2018, 9, 787. [CrossRef] [PubMed]
47. Jose, P.A.; Jha, B. Intertidal marine sediment harbours actinobacteria with promising bioactive and biosynthetic potential. Sci. Rep. 2017, 7, 10041. [CrossRef] [PubMed]
48. Sarmiento-Vizcaíno, A.; González, V.; Braña, A.F.; Palacios, J.J.; Otero, L.; Fernández, J.; Molina, A.; Kulik, A.; Vázquez, F.; Acuña, J.L.; et al. Pharmacological potential of phylogenetically diverse actinobacteria isolated from deep-sea coral ecosystems of the submarine Avilés canyon in the cantabrian sea. Microb. Ecol. 2017, 73, 338–352. [CrossRef] [PubMed]
49. Patin, N.V.; Schorn, M.; Aguinaldo, K.; Lincecum, T.; Moore, B.S.; Jensen, P.R. Effects of actinomycete secondary metabolites on sediment microbial communities. Appl. Environ. Microbiol. 2017, 83, e02676-16. [CrossRef] [PubMed]
50. Medema, M.H.; Fischbach, M.A. Computational approaches to natural product discovery. Nat. Chem. Biol. 2015, 11, 639–648. [CrossRef] [PubMed]
51. Weber, T.; Kim, H.U. The secondary metabolite bioinformatics portal: Computational tools to facilitate synthetic biology of secondary metabolite production. Synth. Syst. Biotechnol. 2016, 1, 69–79. [CrossRef] [PubMed]
52. Blin, K.; Medema, M.H.; Kottmann, R.; Lee, S.Y.; Weber, T. The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters. Nucleic Acids Res. 2017, 45, D555–D559. [CrossRef] [PubMed]
53. Sánchez-Hidalgo, M.; González, I.; Díaz-Muñoz, C.; Martínez, G.; Genilloud, O. Comparative Genomics and Biosynthetic Potential Analysis of Two Lichen-Isolated Amycolatopsis Strains. Front. Microbiol. 2018, 9, 369. [CrossRef] [PubMed]
54. Adamek, M.; Alanjary, M.; Sales-Ortells, H.; Goodfellow, M.; Bull, A.T.; Winkler, A.; Wibberg, D.; Kalinowski, J.; Ziemert, N. Comparative genomics reveals phylogenetic distribution patterns of secondary metabolites in Amycolatopsis species. BMC Genomics 2018, 19, 426. [CrossRef] [PubMed]
55. Zhou, Z.; Gu, J.; Li, Y.-Q.; Wang, Y. Genome plasticity and systems evolution in Streptomyces. BMC Bioinform. 2012, 13, S8. [CrossRef] [PubMed]
56. Kim, J.-N.; Kim, Y.; Jeong, Y.; Roe, J.-H.; Kim, B.-G.; Cho, B.-K. Comparative Genomics Reveals the Core and Accessory Genomes of Streptomyces Species. J. Microbiol. Biotechnol. 2015, 25, 1599–1605. [CrossRef] [PubMed]
57. Choudoir, M.J.; Pepe-Ranney, C.; Buckley, D.H. Diversification of Secondary Metabolite Biosynthetic Gene Clusters Coincides with Lineage Divergence in Streptomyces. Antibiotics 2018, 7, 12. [CrossRef] [PubMed]
58. Zhang, M.M.; Wang, Y.; Ang, E.L.; Zhao, H. Engineering microbial hosts for production of bacterial natural products. Nat. Prod. Rep. 2016, 33, 963–987. [CrossRef] [PubMed]
59. Myronovskyia, M.; Luzhetskyy, A. Native and engineered promoters in natural product discovery. Nat. Prod. Rep. 2016, 33, 1006–1020. [CrossRef] [PubMed]
60. Weber, T.; Charusanti, P.; Musiol-Kroll, E.M.; Jiang, X.; Tong, Y.; Hyun Uk Kim, H.U.; Lee, S.Y. Metabolic engineering of antibiotic factories: New tools for antibiotic production in actinomycetes. Trends Biotechnol. 2015, 33, 15–26. [CrossRef] [PubMed]
61. Ren, H.; Wang, B.; Zhao, H. Breaking the silence: New strategies for discovering novel natural products. Curr. Opin. Biotechnol. 2017, 48, 21–27. [CrossRef] [PubMed]
62. Li, L.; Zhenga, G.; Chena, J.; Gec, M.; Jianga, W.; Lu, Y. New strategies and approaches for engineering biosynthetic gene clusters of microbial natural products. Metab. Eng. 2017, 40, 80–92. [CrossRef] [PubMed]
63. Tong, Y.; Robertsen, H.L.; Blin, K.; Weber, T.; Lee, S.Y. CRISPR-Cas9 Toolkit for Actinomycete Genome Editing. In Synthetic Metabolic Pathways; Humana Press: New York, NY, USA, 2018; pp. 163–184.
64. Xu, M.; Wang, Y.; Zhao, Z.; Gao, G.; Huang, S.-X.; Kang, Q.; He, X.; Lin, S.; Pang, X.; Deng, Z.; et al. Functional genome mining for metabolites encoded by large gene clusters through heterologous expression of a whole-genome bacterial artificial chromosome library in Streptomyces spp. Appl. Environ. Microbiol. 2016, 82, 5795–5805. [CrossRef] [PubMed]
65. Arakawa, K. Manipulation of metabolic pathways controlled by signaling molecules, inducers of antibiotic production, for genome mining in Streptomyces spp. Antonie van Leeuwenhoek 2018, 111, 743–751. [CrossRef] [PubMed]
66. Baltz, R.H. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes. J. Ind. Microbiol. Biotechnol. 2016, 43, 343–370. [CrossRef] [PubMed]
67. Hwang, K.-S.; Kim, H.U.; Charusanti, P.; Palsson, B.O.; Lee, S.Y. Systems biology and biotechnology of Streptomyces species for the production of secondary metabolites. Biotechnol. Adv. 2014, 32, 255–268. [CrossRef] [PubMed]
68. Horbal, L.; Siegl, T.; Luzhetskyy, A. A set of synthetic versatile genetic control elements for the efficient expression of genes in Actinobacteria. Sci. Rep. 2018, 8, 491. [CrossRef] [PubMed]
69. Goh, E.B.; Yim, G.; Tsui, W.; McClure, J.; Surette, M.G.; Davies, J. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics Proc. Natl. Acad. Sci. USA 2002, 99, 17025–17030. [CrossRef] [PubMed]
70. Rosen, P.C.; Seyedsayamdost, M.R. Though much is taken, much abides: Finding new antibiotics using old ones. Biochemistry 2017, 56, 4925–4926. [CrossRef] [PubMed]
71. Okada, B.K.; Seyedsayamdost, M.R. Antibiotic dialogues: Induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol. Rev. 2017, 41, 19–33. [CrossRef] [PubMed]
72. Goodwin, C.R.; Covington, B.C.; Derewacz, D.K.; McNees, C.R.; Wikswo, J.P.; McLean, J.A.; Bachmann, B.O. Structuring microbial metabolic responses to multiplexed stimuli via self-organizing metabolomics maps. Chem. Biol. 2015, 22, 661–670. [CrossRef] [PubMed]
73. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with GNPS. Nat. Biotechnol. 2016, 34, 828–837. [CrossRef] [PubMed]
74. Pérez-Victoria, I.; Martín, J.; Reyes, F. Combined LC/UV/MS and NMR strategies for the dereplication of marine natural products. Planta Med. 2016, 82, 857–871. [CrossRef] [PubMed]
75. Wu, C.; Du, C.; Ichinose, K.; Choi, Y.H.; van Wezel, G.P. Discovery of C-Glycosylpyranonaphthoquinones in Streptomyces sp. MBT76 by a Combined NMR-Based Metabolomics and Bioinformatics Workflow. J. Nat. Prod. 2017, 80, 269. [CrossRef] [PubMed]
76. Gubbens, J.; Zhu, H.; Girard, G.; Song, L.; Florea, B.I.; Aston, P.; Ichinose, K.; Filippov, D.V.; Choi, Y.H.; Overkleeft, H.S.; et al. Natural product proteomining, a quantitative proteomics platform, allows rapid discovery of biosynthetic gene clusters for different classes of natural products. Chem. Biol. 2014, 21, 707. [CrossRef] [PubMed]
77. Chao Du, C.; van Wezel, G.P. Mining for microbial gems: Integrating proteomics in the postgenomic natural product discovery pipeline. Proteomics 2018. [CrossRef]
78. Hou, B.; Lin, Y.; Wu, H.; Guo, M.; Petkovic, H.; Tao, L.; Zhu, X.; Ye, J.; Zhang, H. The novel transcriptional regulator LmbU promotes lincomycin biosynthesis through regulating expression of its target genes in Streptomyces lincolnensis. J. Bacteriol. 2018, 200, e00447-17. [CrossRef] [PubMed]
79. Liu, G.; Chater, K.F.; Chandra, G.; Niu, G.; Tan, H. Molecular regulation of antibiotic biosynthesis in Streptomyces. Microbiol. Mol. Biol. Rev. 2013, 77, 112–143. [CrossRef] [PubMed]
80. Van Wezel, G.P.; Mcdowall, K.J. The regulation of the secondary metabolism of Streptomyces: New links and experimental advances. Nat. Prod. Rep. 2011, 28, 1311–1333. [CrossRef] [PubMed]
81. Hoskisson, P.A.; Fernández-Martínez, L.T. Regulation of specialised metabolites in actinobacteria–expanding the paradigms. Environ. Microbiol. Rep. 2018, 10, 231–238. [CrossRef] [PubMed]
82. Bailey, T.L.J.; Grant, C.E.; Noble, W.S. The MEME suite. Nucleic Acids Res. 2015, 43, W39–W49. [CrossRef] [PubMed]
83. Rigali, S.; Anderssen, S.; Naômé, A.; van Wezel, G.P. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery. Biochem. Pharmacol. 2018, 153, 24–34. [CrossRef] [PubMed]
84. Hiard, S.; Marée, R.; Colson, S.; Hoskisson, P.A.; Titgemeyer, F.; van Wezel, G.P.B.; Wehenkel, J.L.; Rigali, S. PREDetector: A new tool to identify regulatory elements in bacterial genomes. Biochem. Biophys. Res. Commun. 2007, 357, 861–864. [CrossRef] [PubMed]
85. Rigali, S.; Titgemeyer, F.; Barends, S.; Mulder, S.; Thomae, A.W.; Hopwood, D.A.; van Wezel, G.P. Feast or famine: The global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep. 2008, 9, 670–675. [CrossRef] [PubMed]
86. Craig, M.; Lambert, S.; Jourdan, S.; Tenconi, E.; Colson, S.; Maciejewska, M.; Ongena, M.; Martin, J.F.; van Wezel, G.; Rigali, S. Unsuspected control of siderophore production by N-acetylglucosamine in streptomycetes. Environ. Microbiol. Rep. 2012, 4, 512–521. [CrossRef] [PubMed]
87. Jourdan, S.; Francis, I.M.; Kim, M.J.; Salazar, J.J.C.; Planckaert, S.; Frère, J.-M.; Matagne, A.; Kerff, F.; Devreese, B.; Loria, R.; et al. The CebE/MsiK transporter is a doorway to the cello-oligosaccharide-mediated Induction of Streptomyces scabies pathogenicity. Sci. Rep. 2016, 6, 27144. [CrossRef] [PubMed]
88. Schniete, J.K.; Cruz-Morales, P.; Selem-Mojica, N.; Fernández-Martínez, L.T.; Hunter, I.S.; Barona-Gómez, F.; Hoskisson, P.A. Expanding primary metabolism helps generatethe metabolic robustness to facilitate antibioticbiosynthesis in Streptomyces. mBio 2018, 9, e02283-17. [CrossRef] [PubMed]
89. Craney, A.; Ozimok, C.; Pimentel-Elardo, S.M.; Capretta, A.; Nodwell, J.R. Chemical perturbation of secondary metabolism demonstrates important links to primary metabolism. Chem. Biol. 2012, 19, 1020–1027. [CrossRef] [PubMed]
90. Seyedsayamdost, M.R. High-throughput platform for the discovery of elicitors of silent bacterial gene clusters. Proc. Natl. Acad. Sci. USA 2014, 111, 7266–7271. [CrossRef] [PubMed]
91. Adnani, N.; Chevrette, M.G.; Adibhatla, S.N.; Zhang, F.; Yu, Q.; Braun, D.R.; Nelson, J.; Simpkins, S.W.; McDonald, B.R.; Myers, C.L.; et al. Coculture of marine invertebrate-associated bacteria and interdisciplinary technologies enable biosynthesis and discovery of a new antibiotic, keyicin. ACS Chem. Biol. 2017, 12, 3093–3102. [CrossRef] [PubMed]
92. Sengesa, C.H.R.; Al-Dilaimib, A.; Marchbankc, D.H.; Wibbergb, D.; Winklerb, A.; Haltlic, B.; Nowrousiand, M.; Kalinowskib, J.; Kerrc, R.G.; Bandow, J.E. The secreted metabolome of Streptomyces chartreusis and implications for bacterial chemistry. Proc. Natl. Acad. Sci. USA 2018, 115, 2490–2495. [CrossRef] [PubMed]